Committee On

Oversight & Government Reform

The FEHBP Prescription Drug Integrity, Transparency, And Cost Savings Act

February 23, 2010

Witnesses

The Honorable Anthony Weiner
NY-9
U.S. House of Representatives
Mr. John O'Brien (testimony)
Senior Adviser to the Director
U.S. Office of Personnel Management
Mr. Patrick McFarland (testimony)
Inspector General
U.S. Office of Personnel Management
The Honorable Sharon Treat, Esq. (testimony)
State Representative from Maine and Executive Director
National Legislative Association on Prescription Drug Prices
Ms. Jasmin Weaver (testimony)
Healthcare Initiatives Legislative Director
Change to Win
Mr. Jonathan Boehm (testimony)
President and Chief Executive Officer
Argus Health Systems, Inc.
Mr. Richard Beck (testimony)
Texas Pharmacy Business Council
Mr. Daniel Adcock (testimony)
Legislative Director
National Active and Retired Federal Employees
Dr. Jacqueline Simon (testimony)
Public Policy Director
American Federation of Government Employees
Ms. Colleen Kelley (testimony)
National President
National Treasury Employees Union
Mr. John Calfee (testimony)
Resident Scholar
American Enterprise Institute
Mr. Larry McNeely II (testimony)
Health Care Advocate
U.S. PIRG